drugset / Trial / NCT06660381
Psilocybin-assisted Treatment for Cannabis Use Disorder
Phase 1
Recruiting
12 enrolled
Johns Hopkins University
Center for Psychedelic and Consciousness Research · collab
NaSingle-groupOpen-labelTreatment
Summary
This pilot study will evaluate the therapeutic potential of psilocybin in people with Cannabis Use Disorder (CUD). This study will examine the impact of psilocybin treatment on cannabis use and related variables in 12 people with CUD. This is an open-label proof-of-concept trial in which participants will complete a 12-week course of study treatment including two psilocybin sessions with psychological support, and follow-up assessments 3 and 6 months after the first psilocybin session.
Timeline
- Start
- 2024-11-08
- Primary completion
- 2026-11
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | — |
| Subject | Psilocybin | Other / unclassified | 35 mg | — |